Controversies of and Unique Issues in Hematopoietic Cell Transplantation for Infant Leukemia
Authors:
- K. Mignon LohKLK. Mignon Loh
- K. Scott BakerKBK. Scott Baker
- Kirk R. SchultzKSKirk R. Schultz
Open Access
- 1 January 2009
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (1) , 79-83
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Insights from clinical studies into the role of the MLL gene in infant and childhood leukemiaBlood Cells, Molecules, and Diseases, 2008
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignanciesBlood, 2006
- Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemiaBlood, 2005
- Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsLeukemia, 2003
- Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal regionThe Lancet, 2002
- Nf1 and Gmcsf Interact in Myeloid LeukemogenesisMolecular Cell, 2000
- Juvenile Myelomonocytic LeukemiaBlood, 1997
- Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cellsNature Genetics, 1996
- Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG studyBritish Journal of Cancer, 1994